Literature DB >> 6775344

Health planners and local public finance--the case for revenue sharing.

B Rocheleau, S Warren.   

Abstract

Little attention has been paid by health planners or researchers to questions of local public finance. However, a review of the literature concerning general revenue sharing (GRS) funds indicated that about $400 million per year from this source is spent on health services and resources. GRS funds, about $6.4 billion per year, are distributed to more than 39,000 State, county, and city governments. The 1976 amendments to the General Revenue Sharing Act eliminated restrictions on the use of the funds, and they can be employed as matching funds for other Federal monies. An exploratory study of the use of GRS funds for health purposes was conducted in several localities, with particular attention to the health systems agencies. Its results confirmed that there are wide variations among localities in the use of revenue-sharing funds to support health services. Also, not only did the health systems agencies' officials have little impact on the allocation of revenue sharing funds, but only in one locale had an HSA official taken a direct role in the budgetary process. Health planners, who were interviewed during the study, described what they considered their agencies' proper role in local budgetary matters.

Mesh:

Year:  1980        PMID: 6775344      PMCID: PMC1422526     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  2 in total

1.  Revenue sharing: implications for policy and research in aging.

Authors:  C L Estes
Journal:  Gerontologist       Date:  1976-04

2.  General revenue sharing funds for the health care of mothers and children.

Authors:  H M Wallace; H Goldstein; A C Oglesby
Journal:  Am J Dis Child       Date:  1977-04
  2 in total
  1 in total

1.  Federal health services grants, 1980.

Authors:  D I Zwick
Journal:  Public Health Rep       Date:  1981 Nov-Dec       Impact factor: 2.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.